Chapter 12 Autoimmune Polyendocrine Syndromes (APS) or Multiple Autoimmune Syndromes (MAS)

Handbook of Systemic Autoimmune Diseases

Volumn 9, Issue , 2008, Pages 135-148

  Betterle, Corrado ^a   Presotto, Fabio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649655575     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(07)00212-7     Document Type: Review

References (94)

1. Adams D.D., and Purves H.D. Abnormal responses in the assay of thyrotropin. Proc. Univ. Otago Med. School 34 (1956) 11-12
2. Addison, T. 1937. Physician to Guy's Hospital. London: New Sydenham Society 1868. Reprinted in Medical Classics; 2, 244-293.
3. Ahonen P., Myllarniemi S., Sipila I., and Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322 (1990) 1829-1836
4. Anderson J.R., Goudie R.B., Gray K.G., and Timbury G.C. Autoantibodies in Addison's disease. Lancet 1 (1957) 1123-1124
5. Arlt W., and Allolio B. Adrenal insufficiency. Lancet 361 (2003) 1881-1893
6. Asamoto H., Oishi M., Akazawa Y., and Tochino Y. Histological and immunological changes in the thymus and other organs in NOD mice. In: Tarui S., Tochino Y., and Nonaka K. (Eds). Insulitis and Type 1 diabetes-Lessons from the NOD Mouse (1986), Academic Press, Tokyo 61-71
7. Badenhoop K., Walfish P.G., Rau H., Fisher S., Nicolay A., Bogner U., Schleusener H., and Usadel K.H. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 80 (1995) 2112-2117
8. Bartolomaeus W.N., O'Donoghue H., Foti D., Lawson C.M., Shellam G.R., and Read W.D. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 64 (1988) 397-405
9. Betterle C. Parathyroid and autoimmunity. Ann. Endocrinol. (Paris) 67 (2006) 147-154
10. Betterle C., Dal Pra C., Mantero F., and Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 23 (2002) 327-364
11. Betterle C., Greggio N.A., and Volpato M. Clinical review: autoimmune polyglandular disease type 1. J. Clin. Endocrinol. Metab. 83 (1998) 1049-1055
12. Betterle C., Lazzarotto F., and Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg?. Clin. Exp. Immunol. 137 (2004) 225-233
13. Betterle C., Mirakian R., Doniach D., Bottazzo G.F., Riley W., and Maclaren N.K. Antibodies to melanocyte in vitiligo. Lancet 1 (1984) 159
14. Betterle C., Zanchetta R., Chen S., and Furmaniak J. Autoantibodies to adrenal, gonadal tissues and steroidogenic enzymes. In: Shoenfeld Y., Gershwin M.E., and Meroni P.L. (Eds). Autoantibodies (2006), Elsevier, Amsterdam 389-401
15. Bjorses P., Halonen M., Palvimo J.J., Kolmer M., Aaltonen J., Ellonen P., Perheentupa J., Ulmanen I., and Peltonen L. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 66 (2000) 378-392
16. Böehm B.O., Maufras B., Seidl S., Holzberger G., Kuhnl P., and Rosak C. The HLA-DQb non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens 37 (1991) 130-132
17. Carpenter C.C.J., Solomon N., Silverberg S.G., Bledsoe T., Northcutt R.C., Klinenberg J.R., Bennett I., and McGebee Harvey A. Schmidt's syndrome (thyroid and adrenal insufficiency): a review of the literature and a report of fifteen new cases including ten instances of co-existent diabetes mellitus. Medicine 43 (1964) 153-180
18. Chen Q.Y., Kukreja A., and Maclaren N.K. The autoimmune polyglandular syndromes. In: De Groot L.J., and Jameson J.L. (Eds). Endocrinology. 4th ed (2001), W.B. Saunders Company, Philadelphia 587-599 Chapter 41
19. Clemente M.G., Meloni A., Obermyer-Straub P., Frau F., Manns M.P., and De Virgilis S. Two cytochrome P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 114 (1998) 324-328
20. Clemente M.G., Obermyer-Straub P., Meloni A., Strassburg C.P., Arangino V., Tukey R.H., De Virgilis S., and Manns M.P. Cytochrome P450 IA2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab. 82 (1997) 1353-1361
21. Coco G., Dal Pra C., Presotto F., Albergoni M.P., Canova C., Pedini B., Zanchetta R., Chen S., Furmaniak J., Rees Smith B., Mantero F., and Betterle C. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J. Clin. Endocrinol. Metab. 91 (2006) 1637-1645
22. Collins S.M., Dominguez M., Ilmarinen T., Costigan C., and Irvine A.D. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin. Lab. Invest. 154 (2006) 1088-1093
23. Dayan C.M., and Daniels G.H. Chronic autoimmune thyroiditis. N. Engl. J. Med. 335 (1996) 99-107
24. Dominguez M., Crushell E., Ilmarinen T., McGovern E., Collins S., Chang B., Fleming P., Irvine A.D., Brosnahan D., Ulmanen I., Murphy N., and Costigan C. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J. Pediatr. Endocrinol. Metab. 19 (2006) 1343-1352
25. Donner H., Braun J., Seidl C., Rau H., Finke R., Ventz M., Walfish P.G., Usadel K.H., and Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82 (1997) 4130-4132
26. Ekwall O., Hedstrand H., Grimelius L., Haavik J., Perheentupa J., Gustafsson J., Husebye E., Kämpe O., and Rorsman F. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352 (1998) 279-283
27. Friedman T.C., Thomas P.M., Fleisher T.A., Feuillan P., Parker R.I., and Cassorla F. Frequent occurrence of asplenism and cholelitiasis in patients with autoimmune polyglandular disease Type 1. Am. J. Med. 91 (1991) 625-630
28. Galavas, N.G., Kemp, E.H., Krohn, K.J.E., Brown, E.M., Watson, P.F., Weetman, A. 2007. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 92, 2107-2114.
29. Gambelunghe G., Falorni A., Ghaderi M., Laureti S., Tortoioli C., Santeusanio F., Brunetti P., and Sanjeevi C. Microsatellite polymorphism of the MHC Class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 84 (1999) 3701-3707
30. Gylling M., Tuomi T., Björses P., Kontiainen S., Partanen J., Christie M.R., Knip M., Perheentupa J., and Miettinen A. Beta-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 85 (2000) 4434-4440
31. Hashimoto H. Zur kenntnis der lymphomatosen veranderung der schilddruse (struma lymphomatosa). Acta Klin. Chir. 97 (1912) 219-248
32. Hedstrand H., Ekwall O., Haavik J., Landgren E., Betterle C., Perheentupa J., Gustafsson J., Husebye E., Rorsmann F., and Kämpe O. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type 1. Biochem. Biophys. Res. Commun. 267 (2000) 456-461
33. Hedstrand H., Ekwall O., Olsson M.J., Landgren E., Kemp H.E., Weetman A., Perheentupa J., Husebye E., Gustafsson J., Betterle C., Kampe O., and Rorsman F. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type 1. J. Biol. Chem. 276 (2001) 35390-35395
34. Heino M., Peterson P., Kudoh J., Shimizu N., Antonarakis S.E., Scott H.S., and Krohn K. APECED mutations in the autoimmune regulator (AIRE) gene. Hum. Mutat. 18 (2001) 205-211
35. Heino M., Scott H.S., Chen Q., Peterson P., Mäenpää U., Papasavvas M.P., Mittaz L., Barras C., Rossier C., Chrousos G.P., Stratakis C.A., Nagamine K., Kudoh J., Shimizu N., Maclaren N., Antonarakis S.E., and Krohn K. Mutation analyses of North American APS-1 patients. Hum. Mutat. 13 (1999) 69-74
36. Hertz K.C., Gazze L.A., Kirkpatrick C.H., and Katz S.I. Autoimmune vitiligo. Detection of antibodies to melanin-producing cells. N. Engl. J. Med. 12 (1977) 634-637
37. Hoek A., Schoemaker J., and Drehhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr. Rev. 18 (1997) 107-134
38. Högenauer C., Meyer R.L., Netto G.J., Bell D., Little K.H., Ferries L., Santa Ana C.A., Porter J.L., and Fordtran J.S. Malabsorption due to cholecystokin deficiency in a patient with autoimmune polyglandular syndrome type 1. N. Engl. J. Med. 344 (2001) 270-274
39. Huang W., Connor E., Dela Rosa T., Muir A., Schatz D., Silverstein J., Crockett S., She J.X., and Maclaren N. Although DR3-DQB1 0201 may be associated with multiple component diseases of the autoimmune polyglandular syndrome, the human leukocyte antigen DR4-DQB1 0302 haplotype is implicated only in beta-cells autoimmunity. J. Clin. Endocrinol. Metab. 81 (1996) 2259-2563
40. Ikegami H. Animal models of autoimmune polyglandular syndrome. Endocrinol. Metab. Clin. North Am. 31 (2002) 431-439
41. Kemp E.H., Ajjan R.A., Husebye E.S., Peterson P., Uibo R., Imrie H., Pearce S.H., Watson P.F., and Weetman A.P. A cytotoxic T lymphocytic antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clin. Endocrinol. 49 (1998) 609-613
42. Kooistra H.S., Rijnberg A., and van den Ingh T.S. Polyglandular deficiency syndrome in a boxer dog: thyroid hormone and glucocorticoid deficiency. Vet. Q. 17 (1995) 59-63
43. Koury E.L., Bottazzo G.F., Pontes de Carcalho L.C., Wick G., and Roitt I.M. Predisposition to organ specific autoimmunity in obese strain (OS) chicken: reactivity to thyroid, gastric, adrenal and pancreatic cytoplasm antigens. Clin. Exp. Immunol. 49 (1982) 273-282
44. Krug J., Williams A.J., Beales P.E., Doniach I., Gale E.A., and Pozzilli P. Parathyroiditis in the non-obese diabetic mouse-a new finding. J. Endocrinol. 131 (1991) 193-196
45. Latinne D., Vandeput Y., De Bruyere M., Bottazzo G.F., Sokal G., and Crabbe J. Addison's diseases: immunological aspects. Tissue Antigens 30 (1987) 23-24
46. Li Y., Song Y., Rais N., Connor E., Schatz D., Muir A., and Maclaren N. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J. Clin. Invest. 97 (1996) 910-914
47. Maclaren N.K., and Riley W.J. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigen-DR3 and/or DR4, except when associated with type 1 autoimmune polyendocrine syndrome. J. Clin. Endocrinol. Metab. 62 (1986) 455-459
48. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., and Tochino Y. Breeding of a non obese diabetic strain of mice. Exp. Anim. 29 (1980) 1-8
49. McIntyre Gass J.D. The syndrome of keratokonjunctivitis superficial moniliasis idiopathic hypoparathyroidism and Addison's disease. Am. J. Ophthalmol. 54 (1962) 660-674
50. McNicol A.M., and Laidler P. The adrenal glands and extra-adrenal paraganglia. In: Lewis P.D. (Ed). Endocrine System (1996), Churchill Livingstone, Philadelphia 59-121
51. Meloni A., Perniola R., Faa V., Corvaglia E., Cao A., and Rosatelli M.C. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J. Clin. Endocrinol. Metab. 87 (2002) 841-846
52. Muir A., and She J.X. Advances in the genetic and immunology of autoimmune polyglandular syndrome II/III and their clinical applications. Ann. Med. Interne 150 (1999) 301-312
53. Myhre A.G., Halonen M., Eskelin P., Ekwall O., Hedstrand H., Rorsman F., Kämpe O., and Husebye E.S. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin. Endocrinol. 54 (2001) 211-217
54. Myhre A.G., Undlien D.E., Lovas K., Uhlving S., Nedrobo B.G., Fougner K.J., Trovik T., Sorhein J.I., and Husebye E.S. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J. Clin. Endocrinol. Metab. 87 (2002) 618-623
55. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J.E., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., and Shimizu N. Positional cloning of the APECED gene. Nat. Genet. 17 (1997) 393-398
56. Neufeld M., and Blizzard R.M. Polyglandular autoimmune diseases. In: Pinchera A., Doniach D., Fenzi G.F., and Baschieri L. (Eds). Symposium on Autoimmune Aspects of Endocrine Disorders (1980), Academic Press, New York 357-365
57. Neufeld M., Maclaren N.K., and Blizzard R.M. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine 60 (1981) 355-362
58. Oelkers W. Adrenal insufficiency. N. Engl. J. Med. 335 (1996) 1206-1212
59. Onodera T., Toniolo A., Ray U.R., Bennett-Johnson A., Knazen R.A., and Notkins A.L. Virus-induced diabetes mellitus. Polyendocrinopathy and autoimmunity. J. Exp. Med. 153 (1981) 1457-1473
60. Papadopoulos K.I., and Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol. (Copenhagen) 122 (1990) 472-478
61. Partanen J., Peterson P., Westman P., Aranko S., and Krohn K. Major histocompatibility complex class II and III in Addison's disease. Hum. Immunol. 41 (1994) 135-140
62. Pearce S.H., Cheetham T., Imrie H., Vaidya B., Barnes N.D., Bilous R.W., Carr D., Meeran K., Shaw N.J., Smith C.S., Toft A.D., Williams G., and Kendall-Taylor P. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British Kindreds with autoimmune polyendocrinopathy type 1. Am. J. Genet. 63 (1998) 1675-1684
63. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 91 (2006) 2843-2850
64. Perheentupa J., and Miettinen A. Type 1 autoimmune polyglandular disease. Ann. Med. Interne 150 (1999) 313-325
65. Perniola R., Falorni A., Clemente M.G., Forini F., Accogli E., and Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur. J. Endocrinol. 143 (2000) 497-503
66. Perniola R., Tamborrino G., Marsigliante S., and De Rinaldis C. Assessment of enamel hypoplasia in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J. Oral Pathol. Med. 27 (1998) 278-282
67. Peterson P., Nagamine K., Scott H., Heino M., Kudoh J., Shimizu N., Antonarakis S.E., and Krohn K.J.E. APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol. Today 19 (1998) 384-386
68. Pitkänen J., Doucas V., Sternsdorf T., Nakjima T., Aratani S., Jensen K., Will H., Vähämurto P., Ollila J., Vihinen M., Scott H.S., Antonarakis S.E., Kudoh J., Shimizu N., Krohn K.J.E., and Peterson P. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. Am. Soc. Biochem. Mol. Biol. 275 (2000) 16802-16809
69. Pontynen N., Miettinen A., Arstila P.T., Kampe O., Alimohammadi M., Vaarala O., Peltonen L., and Ulmanen I. AIRE deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J. Autoimmun. 27 (2006) 96-104
70. Roitt I.M., Doniach D., Campbell P.N., and Hudson R.V. Autoantibodies in Hashimoto's disease. Lancet 2 (1956) 820-821
71. Rorsman F., Husebye E.S., Winqvist O., Biörk E., Karlsson F.A., and Kämpe O. Aromatic-l-amino-acid decarboxylase, a pyridoxal phosphatase-dependent enzyme, is a novel beta-cell autoantigen. Proc. Natl. Acad. Sci. USA 92 (1995) 8626-8629
72. Rosatelli M.C., Meloni A., Meloni A., Devoto M., Cao A., Scott H.S., Peterson P., Heino M., Krohn K.J.E., Nagamine K., Kudoh J., Shimizu N., and Antoniakis S.E. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy patients. Hum. Genet. 103 (1998) 428-434
73. In: Rose N., and MacKay I.R. (Eds). The Autoimmune Diseases (2006), Elsevier, Academic Press, San Diego
74. Rose N.R., and Witebsky E. Studies in organ specificity. V. Changes in the thyroid glands of rabbit following active immunization with rabbit thyroid extracts. J. Immunol. 76 (1956) 417-427
75. Sakaguchi S., and Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J. Immunol. 142 (1989) 471-480
76. Sato K., Imamura H., Degughi T., Horinouchi S., Yamazaki E., Kanaji Y., and Takano K. A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Endocr. J. 49 (2002) 625-633
77. Schatz D.A., and Winter W.E. Autoimmune polyglandular syndrome type II: clinical syndrome and treatment. Endocrinol. Metab. Clin. North Am. 31 (2002) 339-352
78. Scoldberg F., Portela-Gomes G.M., Grimelius M., Nilsson G., Perheentupa J., Betterle C., Husebye E.S., Gustafsson J., Ronnblom A., Rorsman F., and Kampe O. Histidine decarboxylase a piridoxal phosphate-dependent enzyme is an autoantigen of gastric enterochromaffin-like cells. J. Clin. Endocrinol. Metab. 88 (2003) 1445-1452
79. Scott H.S., Heino M., Peterson P., Mittaz L., Lalioti M.D., Betterle C., Cohen A., Seri M., Lerone M., Romeo G., Collin P., Salo M., Metcalfe R., Weetman A., Papasavvas M.P., Rossier C., Nagamine K., Kudoh J., Shimizu N., Krohn K.J., and Antonarakis S.E. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol. Endocrinol. 12 (1998) 1112-1119
80. Stolarski B., Pronicka E., Korniszewski L., Pollak A., Kostrzewa G., Rowinska E., Wlodarski P., Skorka A., Gremida M., Krajewski P., and Ploski R. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin. Genet. 70 (2006) 348-354
81. Tadmor B., Putterman C., and Naparstek Y. Embryonal germ-layer antigens: target for autoimmunity. Lancet 339 (1992) 975-978
82. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 17 (1997) 399-403
83. Trebusak Podkrajsek K., Bratanic N., Krzisnik C., and Battelino C. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. J. Clin. Endocrinol. Metab. 90 (2005) 4930-4935
84. Tuomi T., Bjorses P., Falorni A., Partanen J., Perheentupa J., Lernmark A., and Miettinen A. Antibodies to glutamic acid decarboxylase and insulin dependent diabetes in patients with autoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 81 (1996) 1488-1494
85. Vaidya B., Pearce S., and Kendall-Taylor P. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure. Clin. Endocrinol. 53 (2000) 403-418
86. Von Mayenburg H. Uber "insulitis" bei diabetes. Schweitz Med. Wochenschr. 71 (1940) 554-557
87. Wang C.Y., Davoodi-Semiromi A., Huang W., Connor E., Shi J.D., and She J.X. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum. Genet. 103 (1998) 681-685
88. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., and Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270 (1995) 985-988
89. Weetman A.P. Graves' disease. N. Engl. J. Med. 343 (2000) 1236-1248
90. Weetman A.P., Zhang L., Tandon N., and Edwards O.M. HLA associations with autoimmune Addison's disease. Tissue Antigen 38 (1991) 31-33
91. Whitaker J., Landing B.H., Esselborn V.M., and Williams R.R. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J. Endocrinol. 16 (1956) 1374-1387
92. Witebsky E., Rose N.R., Terplan K., Paine J.R., and Egan R.W. Chronic thyroiditis and autoimmunization. JAMA 164 (1957) 1439-1447
93. Wolff A.S.B., Erichsen M.M., Meager A., Magitta N.F., Myhre A.G., Bollerslev J., Fougner K.J., Lima K., Knappskog P.M., and Husebye E.S. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway-phenotypic variation, autoantibodies and novel mutations in the autoimmune regulator (AIRE) gene. J. Clin. Endocrinol. Metab. 92 (2007) 595-603
94. Zlotogora J., and Shapiro M.S. Polyglandular autoimmune syndrome type 1 among Iranian Jews. J. Med. Genet. 29 (1992) 824-826